Area of research
Pulmonary and Respiratory Medicine · Rheumatology
Research interest
Research interests include Vasculitis and related conditions, Otitis Media and Relapsing Polychondritis, Systemic Lupus Erythematosus Research, and Coagulation, Bradykinin, Polyphosphates, and Angioedema.
Management of Takayasu Arteritis - A 2026 Update.
ANCA-associated vasculitis in patients with rheumatoid arthritis: A single-center cohort study
Assessment of damage in Takayasu's arteritis.
Highlights from the breakout session: other forms of vasculitis.
A glossary of signs and symptoms of giant cell arteritis
JAKing down glucocorticoids in giant cell arteritis
Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica.
Relapses in giant cell arteritis: Updated review for clinical practice
Reappraisal of large artery involvement in giant cell arteritis: a population-based cohort over 70 years
Assessment of damage in Takayasu’s arteritis
Reappraisal of large artery involvement in giant cell arteritis: a population-based cohort over 70 years.
Improving on Intuition: Assessing Disease Activity in Takayasu Arteritis.
Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica
The provisional OMERACT ultrasonography score for giant cell arteritis.
Prevalence and characteristics of giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica – a prospective cohort study
Recent advances in the treatment of giant cell arteritis
Prevalence and characteristics of giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica - a prospective cohort study.
Extended ultrasound examination identifies more large vessel involvement in patients with giant cell arteritis.
Improved outcomes in rheumatoid arthritis with obesity after a weight loss intervention: randomized trial.
New Therapeutic Approaches to Large-Vessel Vasculitis
Recent advances in the treatment of giant cell arteritis
Correspondence on 'Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients'.
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study
Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis
The provisional OMERACT ultrasonography score for giant cell arteritis
Improved outcomes in rheumatoid arthritis with obesity after a weight loss intervention: randomized trial
Hypothyroidism in vasculitis.
Self-Reported Data and Physician-Reported Data in Patients With Eosinophilic Granulomatosis With Polyangiitis: Comparative Analysis.
Clinical Heterogeneity of the VEXAS Syndrome
Functional Index-3: A Valid and Reliable Functional Outcome Assessment Measure in Patients With Dermatomyositis and Polymyositis.